Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Rev Iberoam Micol ; 37(2): 68-71, 2020.
Article in English | MEDLINE | ID: mdl-32493666

ABSTRACT

BACKGROUND: Cutaneous congenital candidiasis (CCC) is a rare condition consisting of invasive fungal infection of the epidermis and dermis that mostly affects preterm infants. Maternal vaginal candidiasis is present in half of the cases, although the occurrence of invasive candidiasis during pregnancy or peripartum period is exceptional. CASE REPORT: We present the case of a full-term infant that was born by vacuum-assisted vaginal delivery to an apparently healthy 33 year-old woman with no history of intravenous drug use or vaginal candidiasis during pregnancy. The newborn showed a diffuse maculopapular rash with respiratory distress and bilateral interstitial lung infiltrates, requiring nasal continuous positive airway pressure support. Blood cultures obtained from the mother due to intrapartum fever yielded Candida albicans. Cultures of vaginal discharge and neonate skin also yielded C. albicans with the same in vitro susceptibly pattern. No alternative source for candidemia was identified. The clinical course after starting a systemic antifungal therapy was favorable in both the mother and the neonate, with clearance of candidemia and resolution of the skin lesions. CONCLUSIONS: CCC must be considered in full-term newborns with maculopapular rash at birth or during the first days of life. The absence of alternative sources for bloodstream infection in the present case suggests a potential etiopathogenic relationship between CCC and maternal candidemia. It is reasonable to rule out postpartum candidemia when CCC is suspected.


Subject(s)
Candidemia/microbiology , Candidiasis, Cutaneous/congenital , Candidiasis, Vulvovaginal/microbiology , Infectious Disease Transmission, Vertical , Pregnancy Complications, Infectious/microbiology , Adult , Antifungal Agents/therapeutic use , Candidemia/drug therapy , Candidiasis, Cutaneous/diagnosis , Candidiasis, Cutaneous/drug therapy , Candidiasis, Cutaneous/transmission , Candidiasis, Vulvovaginal/drug therapy , Continuous Positive Airway Pressure , Female , Humans , Infant, Newborn , Lung Diseases, Fungal/congenital , Lung Diseases, Fungal/drug therapy , Lung Diseases, Fungal/therapy , Maternal-Fetal Exchange , Pregnancy , Pregnancy Complications, Infectious/drug therapy , Puerperal Disorders/drug therapy , Puerperal Disorders/microbiology , Vacuum Extraction, Obstetrical
2.
Rev. iberoam. micol ; 23(2): 94-96, jun. 2006. ilus
Article in English | IBECS | ID: ibc-75369

ABSTRACT

Las pruebas actuales de estudio de la sensibilidad in vitro a la caspofungina de los aislamientos de Aspergillus están limitadas porque se carece de puntos de corte para su interpretación. Sin embargo, se ha recomendado utilizar caspofungina en el tratamiento de la aspergilosis invasora. Esta actuación puede conducir a un fallo terapéutico como en el caso de una paciente de 55 años que, ocho meses después de ser diagnosticada de leucemia y ser sometida con éxito a un trasplante alogénico de precursores hematopouyéticos, sufrió una aspergilosis pulmonar con desenlace fatal que no respondió al tratamiento de caspofungina(AU)


Currently, susceptibility testing of Aspergillus isolates towards caspofungin is hampered by a lack of interpretative cut-off values. Nevertheless, caspofungin has been widely recommended for the treatment of invasive aspergillosis. This antifungal, however, could lead to therapy failure as demonstrated by the case in this report of a 55-year-old patient, who eight months after the diagnosis of leukemia and successful allogenic hematopoietic stem cell transplantation (HSCT), succumbed to a fatal pulmonary aspergillosis infection, which resisted treatment with caspofungin(AU)


Subject(s)
Humans , Female , Middle Aged , Antifungal Agents/therapeutic use , Aspergillosis/drug therapy , Aspergillosis/etiology , Acute Disease , Lung Diseases, Fungal/congenital , Lung Diseases, Fungal/drug therapy , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bone Marrow Diseases/chemically induced , Bone Marrow Diseases/immunology , Candidiasis/complications , Candidiasis/drug therapy , Combined Modality Therapy , Echinocandins , Fatal Outcome , Hematopoietic Stem Cell Transplantation , Triazoles
3.
J Perinatol ; 25(10): 680-2, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16193080

ABSTRACT

We present a full-term female infant with congenital candidiasis characterized by extensive vesicular and pustular skin lesions associated with pneumonia and severe respiratory distress that appeared during the first hours after birth. The patient was born by cesarean section with no history of rupture of membranes. The mother had a vaginal discharge 3 weeks before delivery. The diagnosis was made by culture of pustular fluid, which grew Candida albicans. Systemic cultures were negative. The infant required a very brief course of conventional mechanical ventilation in spite of impressive and extensive lung infiltrates on the chest radiograph. She made a very quick clinical recovery although it is remarkable that antifungal treatment with amphotericin B was begun very late in her clinical course at the time when she was showing obvious signs of major improvement. Current management guidelines strongly recommend specific therapy for infants with invasive congenital candidiasis or with burn-like extensive dermatitis even without lung involvement. We are not suggesting any change in these recommendations; however, at least in our patient, when amphotericin B was started, she was clearly recovering; it seems possible that her disease although extensive might have experienced an unusual spontaneous regression. This case can provide further insights into this unusual neonatal infection.


Subject(s)
Candidiasis/congenital , Amphotericin B/therapeutic use , Candidiasis, Cutaneous/congenital , Female , Humans , Infant, Newborn , Lung Diseases, Fungal/congenital , Pneumonia/congenital , Remission, Spontaneous
5.
J Perinatol ; 9(2): 159-61, 1989 Jun.
Article in English | MEDLINE | ID: mdl-2661761

ABSTRACT

A term newborn with Candida albicans infection of the lungs and blood is described. Although no maternal risk factors were identified, this patient's rapid clinical deterioration and postmortem findings suggest congenital infection. Related cases in the literature are reviewed. This case suggests that a diagnosis of fungal pneumonia should be considered in any infant presenting with severe respiratory distress.


Subject(s)
Candidiasis/congenital , Lung Diseases, Fungal/congenital , Pneumonia/congenital , Adult , Candidiasis/blood , Female , Humans , Infant, Newborn , Pregnancy , Respiratory Distress Syndrome, Newborn/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...